When Judy Parnitzke learned she had cervical cancer, she immediately knew she needed to trust her instincts and follow the treatment plan her doctors recommended. Nine years later, she looks back at her time at Ackerman Cancer Center and how her faith, family, and doctors got her through her treatment time.
Protect your skin, both during the summer months and all year round, with this convenient skin cancer prevention guide.
Getting started with an exercise regimen is difficult, but has many rewards. It improves your overall quality of life and reduces risk of heart disease, osteoporosis, and depression. You can even be reimbursed by some insurances for having a gym membership.
Women who take a regular dose of baby aspirin may reduce their risk of breast cancer, according to a study published May 1 in Breast Cancer Research. The study is the first of its kind to suggest that the low-dose aspirin and not regular (325 mg) aspirin is associated with breast cancer risk reduction.
Once a month, a group of very important people gathers at Ackerman Cancer Center to share information and their experiences of living with the lung cancer that connects them. The Living with Lung Cancer Support Network was born when Dr. Paul Clark, Assistant Professor of Sociology, Anthropology and Social Work at the University of North Florida, learned from friend and research partner, Jennifer Maggiore (Ackerman Cancer Center Director of Patient Services) that there were virtually no cancer support groups in the area for those affected by lung cancer.
A group of 5th and 6th grade students at Orange Park Elementary are making the world just a little warmer. For the past four or five years, Orange Park Elementary teacher turned librarian, Mary Pat Callihan, along with fellow teacher Karen Walker, have hosted an after school club that makes quilts for patients at Wolfson’s Children Hospital. This year, the students added mastectomy pillows to their repertoire. When Mrs. Callihan became a patient at Ackerman Cancer Center, the students decided they needed to make pillows for the ACC patients as well.
Early in April 2017, the FDA approved a DNA test kit for home use. Developed by the genetic testing company, 23andMe, the kit reveals an individual’s genetic risk for developing 10 diseases including Parkinson’s, Alzheimer’s, celiac and a variety of blood diseases. It is the first kit of its kind to receive FDA approval for home use.
A recent New York Times article highlighted the use of Stereotactic Body Radiation Therapy, or SBRT, for the treatment of prostate cancer. Although the use of SBRT for prostate cancer treatment has risen significantly in recent years, the article called into question the wisdom of using the high dose radiation delivery system near the delicate structures surrounding the prostate gland, touting a lack of solid evidence proving its effectiveness. Understandably, the article generated questions and concerns from a number of our patients and I feel it is important to address the issue.
Most of us are not prepared for the physical, emotional or financial toll a cancer diagnosis brings. From those who carry high-end health insurance to under- or uninsured patients, it is common to have questions about what to expect in the way of coverage and personal expense. No one understands the financial burden of cancer better than Charlotte Sadler, Ackerman Cancer Center’s Financial Resource Coordinator. Committed to helping any way she can, Charlotte’s role is to walk patients through the benefits offered by their specific insurance plans, determine the individual financial responsibility associated with the plan and, when necessary, assist ACC patients in locating additional financial resources.
Researchers have found that focused ultrasound can be used for treatment of a variety of cancers, as it has the potential to adjust for breathing movement in patients. Scientists at the Fraunhofer Institute for Medical Image Computing MEVIS in Bremen, Germany are working on the TRANS-FUSIMO EU, a focused ultrasound therapy concept that can accurately track liver movement to deliver cancer-fighting ultrawaves.